Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro

Jeffrey Fair, Bruce A. Cairns, Michael A. LaPaglia, Montserrat Caballero, W. Andrew Pleasant, Seigo Hatada, Hyung Suk Kim, Tong Gui, Larysa Pevny, Anthony A. Meyer, Darrel W. Stafford, Oliver Smithies, Jeffrey A. Frelinger

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Murine embryonic stem (ES) cells are pluripotent, but significant functional engraftment does not occur when they are introduced into the liver. However, here we demonstrate that functional liver engraftment does occur if the ES cells (from strain 129 mice) are first differentiated in vitro for 7 days in the presence of FGF. Strikingly, when these differentiated cells, termed putative endodermal precursors (PEPs), were injected into their livers, two of six C57BL/6 and four of eight BALB/c factor IX (F-IX)-deficient mice survived for >7 days, even though the recipients were of a different strain and, in the case of the BALB/c recipients, had a complete MHC mismatch. F-IX was detected in all six of the PEP-injected survivors. Two mice subsequently died of causes unrelated to F-IX; the others survived until death at 38 or 115 days after the transplantation. No uninjected control F-IX-deficient mice survived for >7 days. Large confluent regions of sinusoidal PEP engraftment were demonstrated by immunofluorescence in the long-term BALB/c survivors. The PEP engraftment was not associated with detectable cell fusion, and the transplantation was accompanied with only a low incidence of teratoma formation.

Original languageEnglish (US)
Pages (from-to)2958-2963
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number8
DOIs
StatePublished - Feb 22 2005
Externally publishedYes

Fingerprint

Hemophilia B
Factor IX
Embryonic Stem Cells
Liver
129 Strain Mouse
Cell Fusion
Teratoma
Cell Transplantation
Fluorescent Antibody Technique
Transplantation
In Vitro Techniques
Mouse Embryonic Stem Cells
Incidence

Keywords

  • Cellular transplantation
  • Gene therapy
  • Hemophilia
  • In vitro differentiation
  • Liver engraftment

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro. / Fair, Jeffrey; Cairns, Bruce A.; LaPaglia, Michael A.; Caballero, Montserrat; Pleasant, W. Andrew; Hatada, Seigo; Kim, Hyung Suk; Gui, Tong; Pevny, Larysa; Meyer, Anthony A.; Stafford, Darrel W.; Smithies, Oliver; Frelinger, Jeffrey A.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 8, 22.02.2005, p. 2958-2963.

Research output: Contribution to journalArticle

Fair, J, Cairns, BA, LaPaglia, MA, Caballero, M, Pleasant, WA, Hatada, S, Kim, HS, Gui, T, Pevny, L, Meyer, AA, Stafford, DW, Smithies, O & Frelinger, JA 2005, 'Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro', Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 8, pp. 2958-2963. https://doi.org/10.1073/pnas.0409840102
Fair, Jeffrey ; Cairns, Bruce A. ; LaPaglia, Michael A. ; Caballero, Montserrat ; Pleasant, W. Andrew ; Hatada, Seigo ; Kim, Hyung Suk ; Gui, Tong ; Pevny, Larysa ; Meyer, Anthony A. ; Stafford, Darrel W. ; Smithies, Oliver ; Frelinger, Jeffrey A. / Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 8. pp. 2958-2963.
@article{4553eb1a57ae43d597604e643e7e1cb6,
title = "Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro",
abstract = "Murine embryonic stem (ES) cells are pluripotent, but significant functional engraftment does not occur when they are introduced into the liver. However, here we demonstrate that functional liver engraftment does occur if the ES cells (from strain 129 mice) are first differentiated in vitro for 7 days in the presence of FGF. Strikingly, when these differentiated cells, termed putative endodermal precursors (PEPs), were injected into their livers, two of six C57BL/6 and four of eight BALB/c factor IX (F-IX)-deficient mice survived for >7 days, even though the recipients were of a different strain and, in the case of the BALB/c recipients, had a complete MHC mismatch. F-IX was detected in all six of the PEP-injected survivors. Two mice subsequently died of causes unrelated to F-IX; the others survived until death at 38 or 115 days after the transplantation. No uninjected control F-IX-deficient mice survived for >7 days. Large confluent regions of sinusoidal PEP engraftment were demonstrated by immunofluorescence in the long-term BALB/c survivors. The PEP engraftment was not associated with detectable cell fusion, and the transplantation was accompanied with only a low incidence of teratoma formation.",
keywords = "Cellular transplantation, Gene therapy, Hemophilia, In vitro differentiation, Liver engraftment",
author = "Jeffrey Fair and Cairns, {Bruce A.} and LaPaglia, {Michael A.} and Montserrat Caballero and Pleasant, {W. Andrew} and Seigo Hatada and Kim, {Hyung Suk} and Tong Gui and Larysa Pevny and Meyer, {Anthony A.} and Stafford, {Darrel W.} and Oliver Smithies and Frelinger, {Jeffrey A.}",
year = "2005",
month = "2",
day = "22",
doi = "10.1073/pnas.0409840102",
language = "English (US)",
volume = "102",
pages = "2958--2963",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8",

}

TY - JOUR

T1 - Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro

AU - Fair, Jeffrey

AU - Cairns, Bruce A.

AU - LaPaglia, Michael A.

AU - Caballero, Montserrat

AU - Pleasant, W. Andrew

AU - Hatada, Seigo

AU - Kim, Hyung Suk

AU - Gui, Tong

AU - Pevny, Larysa

AU - Meyer, Anthony A.

AU - Stafford, Darrel W.

AU - Smithies, Oliver

AU - Frelinger, Jeffrey A.

PY - 2005/2/22

Y1 - 2005/2/22

N2 - Murine embryonic stem (ES) cells are pluripotent, but significant functional engraftment does not occur when they are introduced into the liver. However, here we demonstrate that functional liver engraftment does occur if the ES cells (from strain 129 mice) are first differentiated in vitro for 7 days in the presence of FGF. Strikingly, when these differentiated cells, termed putative endodermal precursors (PEPs), were injected into their livers, two of six C57BL/6 and four of eight BALB/c factor IX (F-IX)-deficient mice survived for >7 days, even though the recipients were of a different strain and, in the case of the BALB/c recipients, had a complete MHC mismatch. F-IX was detected in all six of the PEP-injected survivors. Two mice subsequently died of causes unrelated to F-IX; the others survived until death at 38 or 115 days after the transplantation. No uninjected control F-IX-deficient mice survived for >7 days. Large confluent regions of sinusoidal PEP engraftment were demonstrated by immunofluorescence in the long-term BALB/c survivors. The PEP engraftment was not associated with detectable cell fusion, and the transplantation was accompanied with only a low incidence of teratoma formation.

AB - Murine embryonic stem (ES) cells are pluripotent, but significant functional engraftment does not occur when they are introduced into the liver. However, here we demonstrate that functional liver engraftment does occur if the ES cells (from strain 129 mice) are first differentiated in vitro for 7 days in the presence of FGF. Strikingly, when these differentiated cells, termed putative endodermal precursors (PEPs), were injected into their livers, two of six C57BL/6 and four of eight BALB/c factor IX (F-IX)-deficient mice survived for >7 days, even though the recipients were of a different strain and, in the case of the BALB/c recipients, had a complete MHC mismatch. F-IX was detected in all six of the PEP-injected survivors. Two mice subsequently died of causes unrelated to F-IX; the others survived until death at 38 or 115 days after the transplantation. No uninjected control F-IX-deficient mice survived for >7 days. Large confluent regions of sinusoidal PEP engraftment were demonstrated by immunofluorescence in the long-term BALB/c survivors. The PEP engraftment was not associated with detectable cell fusion, and the transplantation was accompanied with only a low incidence of teratoma formation.

KW - Cellular transplantation

KW - Gene therapy

KW - Hemophilia

KW - In vitro differentiation

KW - Liver engraftment

UR - http://www.scopus.com/inward/record.url?scp=20044389071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044389071&partnerID=8YFLogxK

U2 - 10.1073/pnas.0409840102

DO - 10.1073/pnas.0409840102

M3 - Article

C2 - 15699326

AN - SCOPUS:20044389071

VL - 102

SP - 2958

EP - 2963

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8

ER -